Q3 2016 Holdings
Filed 2016-11-14 | 134 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | $17 | 20,084 | 0.0% |
| Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | $90 | 13,253 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | COM | 16383L106 | $296 | 49,064 | 0.0% |
| La Jolla Pharmaceutical Company(LJPC) | COM PAR $.0001 2 | 503459604 | $327 | 13,746 | 0.0% |
| ProNAi Therapeutics, Inc. | COM | 74346L101 | $364 | 200,000 | 0.0% |
| CytRx Corporation | COM PAR $.001 | 232828509 | $388 | 659,995 | 0.0% |
| Achaogen, Inc. | COM | 004449104 | $479 | 100,000 | 0.0% |
| Foundation Medicine, Inc. | COM | 350465100 | $488 | 20,892 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $567 | 210,021 | 0.0% |
| Abeona Therapeutics Inc.(ABEO1EUR) | COM | 00289Y107 | $610 | 101,680 | 0.0% |
| Chimerix, Inc.(CMRXEUR) | COM | 16934W106 | $638 | 115,216 | 0.0% |
| Windtree Therapeutics, Inc. | COM | 97382D105 | $653 | 254,973 | 0.0% |
| Ritter Pharmaceuticals, Inc. | COM | 767836109 | $672 | 400,000 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $732 | 57,762 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | COM NEW | 268158201 | $787 | 75,000 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | COM | 45665G303 | $905 | 580,400 | 0.0% |
| Aptose Biosciences Inc. | COM NEW | 03835T200 | $909 | 404,211 | 0.0% |
| Mast Therapeutics, Inc. | COM | 576314108 | $944 | 8,584,051 | 0.0% |
| Tenax Therapeutics, Inc. | COM | 88032L100 | $972 | 420,000 | 0.0% |
| Five Prime Therapeutics, Inc.(FPRX) | COM | 33830X104 | $1.0K | 19,247 | 0.0% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $1.0K | 28,765 | 0.0% |
| Affimed N.V. | COM | N01045108 | $1.1K | 400,000 | 0.0% |
| Immune Design Corp. | COM | 45252L103 | $1.1K | 148,937 | 0.0% |
| Fulgent Genetics, Inc.(FLGT) | COM | 359664109 | $1.2K | 125,000 | 0.0% |
| CoLucid Pharmaceuticals, Inc. | COM | 19716T101 | $1.2K | 30,310 | 0.0% |
| Palatin Technologies, Inc. | COM PAR $.01 | 696077403 | $1.3K | 2,050,000 | 0.0% |
| Seres Therapeutics, Inc.(MCRB1EUR) | COM | 81750R102 | $1.5K | 125,000 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $1.6K | 100,000 | 0.0% |
| Ophthotech Corporation | COM | 683745103 | $1.6K | 35,649 | 0.0% |
| MediWound Ltd. | ORD SHS | M68830104 | $1.7K | 226,000 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $1.8K | 230,000 | 0.0% |
| Assembly Biosciences, Inc. | COM | 045396108 | $1.8K | 250,000 | 0.0% |
| Scynexis, Inc. | COM | 811292101 | $1.8K | 467,600 | 0.0% |
| Enanta Pharmaceuticals, Inc.(ENTA) | COM | 29251M106 | $2.0K | 75,357 | 0.0% |
| Ionis Pharmaceuticals, Inc.(IONS) | COM | 462222100 | $2.1K | 57,140 | 0.0% |
| Karyopharm Therapeutics Inc.(KPTIEUR) | COM | 48576U106 | $2.1K | 216,990 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $2.3K | 232,481 | 0.0% |
| Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | NOTE 4.5% 9/15/2018 | 74365AAB7 | $2.3K | $3,423,000 | 0.0% |
| Juno Therapeutics, Inc. | COM | 48205A109 | $2.4K | 80,000 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $2.5K | 350,000 | 0.0% |
| Osiris Therapeutics, Inc. | COM | 68827R108 | $2.5K | 499,193 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | COM | 816212104 | $2.6K | 178,950 | 0.0% |
| Aeglea BioTherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $2.6K | 404,230 | 0.0% |
| Endocyte, Inc. | COM | 29269A102 | $2.7K | 868,983 | 0.0% |
| InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | $2.7K | 400,000 | 0.0% |
| GlycoMimetics, Inc.(GLYCEUR) | COM | 38000Q102 | $2.7K | 381,235 | 0.0% |
| Proteon Therapeutics, Inc. | COM | 74371L109 | $2.8K | 298,591 | 0.0% |
| Adamas Pharmaceuticals, Inc.(ADMSEUR) | COM | 00548A106 | $2.8K | 172,630 | 0.0% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $2.8K | 204,465 | 0.0% |
| Trevena, Inc. | COM | 89532E109 | $3.0K | 450,000 | 0.0% |